Search for Clinical Trial Results
![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Noonan Syndrome - 30 Studies Found
Status | Study |
Completed |
Study Name: Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome Condition: Noonan Syndrome Date: 2007-03-23 Interventions: Drug: MAXOMAT ®, biosynthetic growth hormone 2 posologies according to age (children and adolescent |
Recruiting |
Study Name: Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome Condition: Noonan Syndrome Date: 2016-03-09 Interventions:
|
Terminated |
Study Name: Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome Condition: Noonan Syndrome Date: 2006-07-11 Interventions: Drug: rhIGF-1/rhIGFBP-3 |
Completed |
Study Name: Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome Condition:
Date: 2012-01-02 Interventions: Drug: somatropin Retrospective data collection based on data obtained from a prospective, open-label, ra |
Active, not recruiting |
Study Name: Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome Condition:
Date: 2013-08-20 Interventions: Drug: somatropin Administered subcutaneously (s.c., under the skin) in a daily regimen for at least 104 |
Not yet recruiting |
Study Name: Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes Condition:
Date: 2014-03-04 |
Completed |
Study Name: Study of Metabolic Modifications in Children With Noonan Syndrome Condition: Child Syndrome Date: 2014-12-23 Interventions: Other: Oral Glucose tolerance test Oral glucose tolerance test (OGTT): glucose and insulin levels will b |
Completed |
Study Name: Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 Condition:
Date: 2012-01-02 Interventions: Drug: somatropin Results from a genetic testing for the PTPN11 mutation will be collected retrospectivel |
Withdrawn |
Study Name: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy Condition: Cardiomegaly Date: 2012-03-15 Interventions: Drug: MEK162 |
Completed |
Study Name: Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol Condition: Mass Screening Date: 2010-10-19 Interventions: Device: Bio-Rad Platelia Dengue NS1 Ag test The purpose of the study is to screen blood donors for the p |